$ACHC
Acadia Healthcare Company, Inc.

2024 Q2 Form 10-Q Financial Statement

#000095017024052085 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $796.0M $768.1M
YoY Change 8.85% 9.06%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $507.6M $501.7M
YoY Change 8.39% 6.81%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $36.07M $36.35M
YoY Change 12.66% 15.14%
% of Gross Profit
Operating Expenses $653.3M $639.1M
YoY Change 9.58% 7.94%
Operating Profit
YoY Change
Interest Expense -$29.16M -$27.21M
YoY Change 39.45% 36.08%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $106.5M $98.84M
YoY Change 10.4% 15.41%
Income Tax $25.64M $20.07M
% Of Pretax Income 24.09% 20.31%
Net Earnings $78.48M $76.38M
YoY Change 8.55% 15.71%
Net Earnings / Revenue 9.86% 9.95%
Basic Earnings Per Share $0.86 $0.84
Diluted Earnings Per Share $0.85 $0.83
COMMON SHARES
Basic Shares Outstanding 92.77M 92.29M
Diluted Shares Outstanding 92.04M 92.01M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.17M $77.30M
YoY Change -31.21% 21.11%
Cash & Equivalents $77.17M $77.30M
Short-Term Investments
Other Short-Term Assets $178.7M $147.3M
YoY Change 189.29% 15.49%
Inventory $5.988M $5.745M
Prepaid Expenses $31.93M $30.19M
Receivables $389.4M $386.2M
Other Receivables $24.01M $0.00
Total Short-Term Assets $645.2M $610.8M
YoY Change 11.48% 13.58%
LONG-TERM ASSETS
Property, Plant & Equipment $2.498B $2.497B
YoY Change 13.45% 24.99%
Goodwill $2.261B $2.261B
YoY Change 1.74% 1.72%
Intangibles $73.35M $73.35M
YoY Change 2.43% -3.8%
Long-Term Investments
YoY Change
Other Assets $74.23M $74.66M
YoY Change -1.53% 2.02%
Total Long-Term Assets $5.033B $4.906B
YoY Change 10.09% 8.88%
TOTAL ASSETS
Total Short-Term Assets $645.2M $610.8M
Total Long-Term Assets $5.033B $4.906B
Total Assets $5.678B $5.517B
YoY Change 10.25% 9.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $159.5M $156.1M
YoY Change 7.14% 24.18%
Accrued Expenses $271.4M $264.7M
YoY Change 30.35% 43.02%
Deferred Revenue $1.801M $2.154M
YoY Change -55.55% -57.74%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $66.57M $61.45M
YoY Change 167.41% 189.19%
Total Short-Term Liabilities $546.5M $482.3M
YoY Change 26.37% 27.55%
LONG-TERM LIABILITIES
Long-Term Debt $1.775B $1.794B
YoY Change 29.31% 28.18%
Other Long-Term Liabilities $150.6M $249.8M
YoY Change -37.47% 93.71%
Total Long-Term Liabilities $1.925B $2.044B
YoY Change 19.34% 33.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $546.5M $482.3M
Total Long-Term Liabilities $1.925B $2.044B
Total Liabilities $2.613B $2.651B
YoY Change 17.24% 25.4%
SHAREHOLDERS EQUITY
Retained Earnings $286.6M $208.1M
YoY Change -1.75% -5.15%
Common Stock $2.666B $2.658B
YoY Change 1.4% 1.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.953B $2.866B
YoY Change
Total Liabilities & Shareholders Equity $5.678B $5.517B
YoY Change 10.25% 9.38%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $78.48M $76.38M
YoY Change 8.55% 15.71%
Depreciation, Depletion And Amortization $36.07M $36.35M
YoY Change 12.66% 15.14%
Cash From Operating Activities $171.1M -$321.3M
YoY Change 4.51% -823.48%
INVESTING ACTIVITIES
Capital Expenditures $154.2M $142.4M
YoY Change 69.81% 114.07%
Acquisitions $50.35M
YoY Change
Other Investing Activities -$1.242M -$42.20M
YoY Change -1981.82% -5415.37%
Cash From Investing Activities -$155.5M -$184.6M
YoY Change 71.3% 175.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.80M 483.1M
YoY Change -35.92% -4368.68%
NET CHANGE
Cash From Operating Activities 171.1M -321.3M
Cash From Investing Activities -155.5M -184.6M
Cash From Financing Activities -15.80M 483.1M
Net Change In Cash -136.0K -22.77M
YoY Change -100.28% -32.67%
FREE CASH FLOW
Cash From Operating Activities $171.1M -$321.3M
Capital Expenditures $154.2M $142.4M
Free Cash Flow $16.91M -$463.7M
YoY Change -76.82% 1996.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001520697
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-35331
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2492228
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6100 Tower Circle
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Franklin
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37067
CY2024Q1 dei City Area Code
CityAreaCode
615
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
861-6000
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
ACHC
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92774604
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77303000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100073000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
386191000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
361451000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
147312000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
134476000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
610806000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
596000000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2376059000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266610000
CY2024Q1 us-gaap Goodwill
Goodwill
2261026000
CY2023Q4 us-gaap Goodwill
Goodwill
2225962000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73352000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73278000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2777000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6658000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
121346000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
117780000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71881000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72553000
CY2024Q1 us-gaap Assets
Assets
5517247000
CY2023Q4 us-gaap Assets
Assets
5358841000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
61452000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29219000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
156130000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
156132000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
118005000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
141901000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26815000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26268000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
119911000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
532261000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
482313000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
885781000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1794296000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1342548000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15527000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1931000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103352000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100808000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
146404000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
140113000
CY2024Q1 us-gaap Liabilities
Liabilities
2541892000
CY2023Q4 us-gaap Liabilities
Liabilities
2471181000
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
109333000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
105686000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91573596
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91573596
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91263989
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91263989
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
916000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
913000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2657002000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2649340000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
208104000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131721000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2866022000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2781974000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5517247000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5358841000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
768051000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
704267000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8678000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7629000
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
417523000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
391177000
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
45688000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
41125000
CY2024Q1 us-gaap Supplies Expense
SuppliesExpense
26652000
CY2023Q1 us-gaap Supplies Expense
SuppliesExpense
26021000
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
11863000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
11424000
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
101073000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
90838000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36347000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31569000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-27214000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19999000
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2847000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6471000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
669207000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
618624000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98844000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
85643000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20074000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19085000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
78770000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
66558000
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2387000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
543000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
76383000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91363000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90101000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92010000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91391000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2812727000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1203000
CY2023Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-48874000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7629000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
902000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2839602000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3784000
CY2023Q2 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-2017000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7348000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
72299000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2921016000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1554000
CY2023Q3 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-843000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8163000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
382000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-217710000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2712562000
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1656000
CY2023Q4 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-798000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9149000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1676000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
57729000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2781974000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4102000
CY2024Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-5115000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8678000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
76383000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2866022000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
78770000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
66558000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36347000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31569000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1016000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
824000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8678000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7629000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17476000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
212000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4094000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1089000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22930000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23968000
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
15629000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
23430000
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-696000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1436000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-403340000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13633000
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-25024000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-30386000
CY2024Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6749000
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2114000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-321285000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44408000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50353000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
142410000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66525000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9056000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
409000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
907000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
794000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-184614000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66910000
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
350000000
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
10242000
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5313000
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1518000
CY2024Q1 achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-1013000
CY2023Q1 achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-47671000
CY2024Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
2280000
CY2023Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
1655000
CY2024Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
1020000
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-358000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
11000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
483129000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11318000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22770000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33820000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100073000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97649000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77303000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63829000
CY2024Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
55309000
CY2024Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
3456000
CY2024Q1 achc Contingent Consideration Issued In Connection With Acquisition
ContingentConsiderationIssuedInConnectionWithAcquisition
1500000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50353000
CY2024Q1 achc Number Of Facilities
NumberOfFacilities
258
CY2024Q1 achc Number Of Beds
NumberOfBeds
11300
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
38
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
76383000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91363000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90101000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
647000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1290000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92010000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91391000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2024Q1 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
23586000
CY2023Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
33579000
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
22867000
CY2022Q4 us-gaap Goodwill
Goodwill
2222805000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
337000
CY2023 achc Increase In Goodwill From Contribution Of Redeemable Non Controlling Interests
IncreaseInGoodwillFromContributionOfRedeemableNonControllingInterests
2820000
CY2023Q4 us-gaap Goodwill
Goodwill
2225962000
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
35064000
CY2024Q1 us-gaap Goodwill
Goodwill
2261026000
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
38427000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
12416000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30190000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
36085000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
22084000
CY2024Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
12865000
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
11496000
CY2024Q1 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2023Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2024Q1 us-gaap Inventory Net
InventoryNet
5745000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5300000
CY2024Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1632000
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1516000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
147312000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
134476000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3172768000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3033956000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
796709000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
767346000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2376059000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266610000
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
73352000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
73278000
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
74483000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
74409000
CY2024Q1 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2023Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2024Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
400000000
CY2024Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
19900000
CY2024Q1 achc Accrued Expense Current
AccruedExpenseCurrent
63582000
CY2023Q4 achc Accrued Expense Current
AccruedExpenseCurrent
80733000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
18446000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
18046000
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12486000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12486000
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
6381000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
7097000
CY2024Q1 achc Cost Report Payable Current
CostReportPayableCurrent
4363000
CY2023Q4 achc Cost Report Payable Current
CostReportPayableCurrent
9265000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2154000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2165000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2023Q4 achc Accrued Desert Hills Settlement Current
AccruedDesertHillsSettlementCurrent
393696000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11509000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7783000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
119911000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
532261000
CY2024Q1 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
11197000
CY2023Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
10421000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1855748000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1371767000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
61452000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29219000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1794296000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1342548000
CY2024Q1 achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
10
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
88257000
CY2023 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
16530000
CY2023 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
6006000
CY2023 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5107000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
105686000
CY2024Q1 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
2280000
CY2024Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
2387000
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1020000
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
109333000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12700000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2253481
CY2024Q1 achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8700000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7600000
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
87900000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y3M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
979277
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.27
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
296340
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
78.94
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
198527
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
41.29
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
140545
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
55.95
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
936545
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.21
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
84.18
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
90178
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
45.49
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
22888
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
62.76
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
824479
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.24
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18435000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
448934
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
47.76
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14197000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.99
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.99
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.34
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2024Q1 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
5238000
CY2023Q1 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
1640000
CY2024Q1 achc Management Transition Costs
ManagementTransitionCosts
1009000
CY2023Q1 achc Management Transition Costs
ManagementTransitionCosts
4800000
CY2024Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
-3400000
CY2023Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
31000
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2847000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6471000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.223
CY2024Q1 ecd Trd Arr Ind Title
TrdArrIndTitle
directors or officers
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-052085-index-headers.html Edgar Link pending
0000950170-24-052085-index.html Edgar Link pending
0000950170-24-052085.txt Edgar Link pending
0000950170-24-052085-xbrl.zip Edgar Link pending
achc-20240331.htm Edgar Link pending
achc-20240331.xsd Edgar Link pending
achc-ex31_1.htm Edgar Link pending
achc-ex31_2.htm Edgar Link pending
achc-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
achc-20240331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable